TREVI THERAPEUTICS, INC. (TRVI) Operating cash flow 2018–2025
TREVI THERAPEUTICS, INC. (TRVI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$42.1MFY2025 · since FY2018: -$18.3M → -$42.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.1M | -10.0% |
| FY2024 | -$38.3M | -20.6% |
| FY2023 | -$31.7M | -12.5% |
| FY2022 | -$28.2M | +2.7% |
| FY2021 | -$28.9M | +0.2% |
| FY2020 | -$29.0M | -25.6% |
| FY2019 | -$23.1M | -26.3% |
| FY2018 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice